OnKure Therapeutics, Inc. (OKUR) — Net Asset Quality Index
OnKure Therapeutics, Inc. (OKUR) has a Net Asset Quality Index of 91.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $72.83 Million minus total liabilities of $6.41 Million yields net assets of $66.43 Million. A higher index indicates a stronger, lower-leverage balance sheet. See OnKure Therapeutics, Inc. defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
OnKure Therapeutics, Inc. Net Asset Quality Index Over Time (2020–2024)
This chart shows how OnKure Therapeutics, Inc.'s Net Asset Quality Index has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the index stands at 91.2%, representing net assets of $66.43 Million against total assets of $72.83 Million USD. Explore cash efficiency ratio of OnKure Therapeutics, Inc. to assess how effectively this company generates cash.
Annual Net Asset Quality Index for OnKure Therapeutics, Inc. (2020–2024)
The table below presents the year-by-year Net Asset Quality Index for OnKure Therapeutics, Inc. from 2020 to 2024, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see OKUR market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 90.4% | $103.83 Million | $114.91 Million | $11.08 Million | ▲ +375.4 pp |
| 2023 | -285.0% | $-101.84 Million | $35.73 Million | $137.58 Million | ▲ +55.1 pp |
| 2022 | -340.1% | $-54.42 Million | $16.00 Million | $70.42 Million | ▼ -435.7 pp |
| 2021 | 95.6% | $147.21 Million | $154.02 Million | $6.81 Million | ▲ +171.8 pp |
| 2020 | -76.3% | $-42.12 Million | $55.22 Million | $97.34 Million | — |